Impact of seasonal RTS,S/AS01


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
22 Feb 2022
Historique:
received: 08 11 2021
accepted: 06 02 2022
entrez: 23 2 2022
pubmed: 24 2 2022
medline: 25 2 2022
Statut: epublish

Résumé

A recent trial in Burkina Faso and Mali showed that combining seasonal RTS,S/AS01 In Burkina Faso and Mali 5920 children were randomized to receive either SMC alone, RTS,S/AS01 In 2017, compared to SMC alone, the combined intervention reduced the prevalence of wasting by approximately 12% [prevalence ratio (PR) = 0.88 (95% CI 0.75, 1.03)], and approximately 21% in 2018 [PR = 0.79 (95% CI 0.62, 1.01)]. Point estimates were similar for comparisons with RTS,S/AS01 Despite a high burden of malnutrition and malaria in the study populations, and a major reduction in the incidence of malaria in children receiving both interventions, this had only a modest impact on nutritional status. Therefore, other interventions are needed to reduce the high burden of malnutrition in these areas. https://www.clinicaltrials.gov/ct2/show/NCT03143218 , registered 8th May 2017.

Sections du résumé

BACKGROUND BACKGROUND
A recent trial in Burkina Faso and Mali showed that combining seasonal RTS,S/AS01
METHODS METHODS
In Burkina Faso and Mali 5920 children were randomized to receive either SMC alone, RTS,S/AS01
RESULTS RESULTS
In 2017, compared to SMC alone, the combined intervention reduced the prevalence of wasting by approximately 12% [prevalence ratio (PR) = 0.88 (95% CI 0.75, 1.03)], and approximately 21% in 2018 [PR = 0.79 (95% CI 0.62, 1.01)]. Point estimates were similar for comparisons with RTS,S/AS01
CONCLUSIONS CONCLUSIONS
Despite a high burden of malnutrition and malaria in the study populations, and a major reduction in the incidence of malaria in children receiving both interventions, this had only a modest impact on nutritional status. Therefore, other interventions are needed to reduce the high burden of malnutrition in these areas.
TRIAL REGISTRATION BACKGROUND
https://www.clinicaltrials.gov/ct2/show/NCT03143218 , registered 8th May 2017.

Identifiants

pubmed: 35193608
doi: 10.1186/s12936-022-04077-x
pii: 10.1186/s12936-022-04077-x
pmc: PMC8864823
doi:

Substances chimiques

Antimalarials 0

Banques de données

ClinicalTrials.gov
['NCT03143218']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Subventions

Organisme : Medical Research Council
ID : MR/P006876/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : United Kingdom Joint Global Health Trials
ID : MR/P006876/1
Organisme : PATH
ID : 18269

Informations de copyright

© 2022. The Author(s).

Références

Lancet. 2020 Dec 5;396(10265):1829-1840
pubmed: 33278936
Am J Trop Med Hyg. 2017 Jan 11;96(1):9-10
pubmed: 27994102
Am J Clin Nutr. 2004 Dec;80(6):1604-10
pubmed: 15585775
Malar J. 2017 May 2;16(1):182
pubmed: 28464937
Antimicrob Agents Chemother. 2009 May;53(5):1753-9
pubmed: 19223620
Lancet. 1995 Feb 25;345(8948):479-83
pubmed: 7861874
BMJ Open. 2020 Sep 15;10(9):e035433
pubmed: 32933955
PLoS Med. 2011 Feb 01;8(2):e1000407
pubmed: 21304923
Br J Nutr. 1977 May;37(3):441-50
pubmed: 861194
PLoS One. 2018 Jan 11;13(1):e0190983
pubmed: 29324840
Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):262-5
pubmed: 8758071
Malar J. 2015 Sep 17;14:346
pubmed: 26377094
PLoS Med. 2011 Feb 01;8(2):e1000408
pubmed: 21304925
Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):68-77
pubmed: 12749488
J Nutr. 2017 Nov;147(11):2163S-2168S
pubmed: 28904111
Am J Trop Med Hyg. 2007 Sep;77(3):411-7
pubmed: 17827352
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
N Engl J Med. 2021 Sep 9;385(11):1005-1017
pubmed: 34432975
Public Health Nutr. 2013 Sep;16(9):1548-57
pubmed: 23507372
Acta Trop. 1997 Apr 30;65(1):1-10
pubmed: 9140509
Malar J. 2010 Oct 29;9:303
pubmed: 21029476
Nutr Res Rev. 2000 Jun;13(1):3-29
pubmed: 19087431

Auteurs

Jane Grant (J)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK. jane.grant2@lshtm.ac.uk.

Issaka Sagara (I)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Issaka Zongo (I)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Matthew Cairns (M)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK.

Rakiswendé Serge Yerbanga (RS)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Modibo Diarra (M)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Charles Zoungrana (C)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Djibrilla Issiaka (D)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Frédéric Nikièma (F)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Frédéric Sompougdou (F)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Amadou Tapily (A)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Mahamadou Kaya (M)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Alassane Haro (A)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Koualy Sanogo (K)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Abdoul Aziz Sienou (AA)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Seydou Traore (S)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Ismaila Thera (I)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Hama Yalcouye (H)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Irene Kuepfer (I)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK.

Paul Snell (P)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK.

Paul Milligan (P)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK.

Christian Ockenhouse (C)

PATH, Seattle, USA.

Opokua Ofori-Anyinam (O)

GlaxoSmithKline Vaccines, Rixensart, Belgium.

Halidou Tinto (H)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Abdoulaye Djimde (A)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Daniel Chandramohan (D)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK.

Brian Greenwood (B)

London School of Hygiene and Tropical Medicine, Keppel St., London, WC1E 7HT, UK.

Alassane Dicko (A)

Malaria Research and Training Center, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Jean-Bosco Ouédraogo (JB)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH